Precipio Inc (TBIO) – Financial and Strategic SWOT Analysis Review Summary Precipio Inc (Precipio), formerly Transgenomic Inc, is a developer and provider of diagnostic tools and services. The company advances personalized medicine for the detection and treatment of cancer, and inherited diseases through its molecular technologies and clinical and research services. It offers ICEme Kits, which finds applications for mutation specific, disease specific and gene… Read More »
Outlook Therapeutics Inc (ONSIU) – Financial and Strategic SWOT Analysis Review Summary Outlook Therapeutics Inc(Outlook Therapeutics) formerly known as Oncobiologics Inc, is a clinical stage biopharmaceutical company that identifies, develops, manufactures and commercializes biosimilar therapeutics in the areas of immunology and oncology. The company’s pipeline products include ONS-3010, an adalimumab biosimilar intended for rheumatoid arthritis, psoriasis, ankylosing spondylitis, psoriatic arthritis, Crohn’s disease and ulcerative colitis; and… Read More »
MTBC Inc (MTBC) – Financial and Strategic SWOT Analysis Review Summary MTBC Inc (MTBC) is a healthcare IT company that offers web-based solutions and related business services. The company offers products such as electronic health records, practice management, patient engagement and mhealth. Its services include offers medical billing, consultancy, medical transcription, business intelligence, document management, and other services. MTBC provides implementation, demo guide and training… Read More »
IMV Inc (IMV) – Financial and Strategic SWOT Analysis Review Summary IMV Inc (IMV), formerly Immunovaccine Inc, is a clinical-stage biopharmaceutical company that develops cancer immunotherapies and infectious disease vaccines. The company’s product candidates include DPX-Survivac, a T cell activating immunotherapy that identifies and disrupts cancer biology in solid and hematological cancers; DPX-E7, an investigational immunotherapy that targets a viral protein in human papillomavirus in… Read More »
OCI International Holdings Ltd. (329) – Financial and Strategic SWOT Analysis Review Summary OCI International Holdings Limited (OCI) is an investment holding company. The company operates in the business of health care products and pharmaceutical products. It offers healthcare products such as Chinese ginseng products, American ginseng products, and multi-vitamin pill. OCI’s pharmaceutical products include azithromycin granules and rosiglitazone hydrochloride capsules. The company’s other activities include property… Read More »
Porton Pharma Solutions Ltd (300363) – Financial and Strategic SWOT Analysis Review Summary Porton Pharma Solutions Ltd (Porton) is a supplier of custom drug intermediates and active pharmaceutical ingredients. The company provides custom and contract chemical development, and contract manufacturing services. It provides products such as reactive reagents, chiral chromatography products, unnatural amino acids and heterocylics, among others. Porton also offers regulatory support for the commercialization of… Read More »
Phio Pharmaceuticals Corp (RXII) – Financial and Strategic SWOT Analysis Review Summary Phio Pharmaceuticals Corp(Phio Pharmaceuticals) formerly known as RXi Pharmaceuticals Corp, is a biotechnology company that discovers, develops and commercializes immuno-oncology therapeutics to treat cancer. The company’s technology sd-rxRNA includes RXI-109 and IncRNA. Its lead product candidate is RXI-109, an sd-rxRNA that reduces the expression of connective tissue growth factor, a critical regulator of several… Read More »
Protek Group (PRTK) – Financial and Strategic SWOT Analysis Review Summary Protek Group (Protek) is a pharmaceutical company. The company manufactures and distributes pharmaceutical, health and beauty care products. Its products comprise CV Protek, Sotex Farm and Rigla Pharmacy Chain. Protek’s CV Protek unit distributes medicines, parapharmaceutical products and medical supplies. The company also manufactures injection solutions of liquid INPN generics and other licensed medicines.… Read More »
Sosei Heptares (4565) – Financial and Strategic SWOT Analysis Review Summary Sosei Heptares(Sosei) formerly known as Sosei Group Corp, is a biopharmaceutical company that develops and commercializes drugs. The company’s pipeline products include NorLevo, NVA237, QVA149 and SO-1105. Its NorLevo product is an oral emergency contraceptive; and SO-1105 is an antifungal agent, administered as a muco-adhesive buccal tablet for the treatment of oropharyngeal candidiasis in… Read More »
Augmenting Demand For RTLS In Healthcare Market Outlook: Ken Research: Ken Research Buy Now According to the report analysis, ‘Global RTLS for Healthcare Market Size study, by Offering (Hardware, Software, Services), by Technology (RFID, Wi-Fi, UWB, BLE, Infrared, Ultrasound, Others), by Application (Inventory Management, Personnel Management, Access Control, Environment Monitoring, Supply Chain Management, Others) and Regional Forecasts 2018-2025’ states that in the worldwide RTLS for the healthcare… Read More »
